MEDLANDER's net profit for the year 2024 is 102 million yuan, a year-on-year increase of 13.75%

MEDLANDER released its 2024 annual performance preliminary report, with total operating revenue of 423 million yuan, a year-on-year increase of 24.02%; net profit attributable to the parent company's owners of 102 million yuan, a year-on-year increase of 13.75%; net profit excluding non-recurring gains and losses of 90.4377 million yuan, a year-on-year increase of 26.42%. Basic earnings per share were 1.0369 yuan. During the reporting period, the company strengthened brand building, optimized sales channels, and achieved rapid growth in sales of reproductive rehabilitation products and accessories

According to the Zhitong Finance APP, MEDLANDER (688273.SH) disclosed its performance preliminary report for 2024, with total operating revenue of 423 million yuan, a year-on-year increase of 24.02%; net profit attributable to the parent company's owners of 102 million yuan, a year-on-year increase of 13.75%; and net profit attributable to the parent company's owners after deducting non-recurring gains and losses of 90.4377 million yuan, a year-on-year increase of 26.42%. Basic earnings per share are 1.0369 yuan.

During the reporting period, the company strengthened brand building, optimized sales channels, and achieved rapid growth in sales of reproductive rehabilitation products, consumables, and accessories